Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Drug Prices to Rise, China Cuts Sops (India)

This article was originally published in PharmAsia News

Executive Summary

China's finance ministry announced recently it will reduce tax rebates for exports from China for about 3,000 various categories, including tax rebates for pharmaceutical products and bulk drug exports, according to export manufacturers. Some drug exporters who sell China-made drugs in India contend that profit margins already are narrow. The new tax rebate sunset will reportedly cause retail drug price increases in India of between 8 percent to 15 percent. Cipla official Amar Lulla in India says the tax move "will affect imports of intermediates and bulk drugs into the country." Satish Reddy, MD and COO of Dr Reddy's Laboratories, says, "The slash in incentives for exports is going to impact active pharmaceutical ingredient (API) manufacturers worldwide." He adds that "this slash also applies to basic chemicals and intermediate exports out of China, so it would result in an increase in input costs for API manufacturers relying on these raw materials from Chinese sources." (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts